National Necrotizing Fasciitis Foundation Says Current Care for Flesh-Eating Disease is Inadequate

Article

The National Necrotizing Fasciitis Foundation (NNFF) today announced a campaign to raise awareness of the tragic inadequacy of the current standard of care for necrotizing fasciitis, or 'flesh-eating' infection -and to push for the adoption of new treatments for this deadly condition. "Too many people are losing their lives or their limbs because the current standard of care simply doesn't work," says Jacqueline Roemmele, executive director of the NNFF. "But there is a promising new treatment that doctors can adopt." 
 
NNFF calls on medical associations like the Association for the Advancement of Wound Care and the American Professional Wound Care Association, to review the evidence supporting the use of new approaches to treatment, and then work with the NNFF on guidelines for their members to improve the standard of care. It also asks the federal government's Centers for Medicare and Medicaid Services (CMS) to evaluate new treatments for necrotizing fasciitis and to approve their reimbursement under Medicare and Medicaid. "These steps will help reduce the tremendous toll that necrotizing fasciitis is taking on patients and their families," says Roemmele.

Necrotizing fasciitis can start with just a minor cut or a scrape. What happens is that bacteria, typically Streptococcus, get under the skin and begin to spread. Then, toxins produced by the bacteria and the body's own immune response eat away tissue. Even with aggressive treatment with antibiotics, the mortality rate is as high as 20 percent. Surviving victims usually lose feet, legs, hands, arms or other body parts. The Centers for Disease Control estimates there are hundreds of cases a year in the U.S. But based on reports to the NNFF and on other evidence, many experts believe the incidence is far higher.

In the current standard of care, doctors flood the body with heavy doses of intravenous antibiotics, while cutting away the dead tissue. The problem is that the toxins typically keep eating away tissue, requiring more and more surgery. That's why so many limbs end up being amputated.

"We founded the NNFF in 1997 to provide information and support to patients and their families," says Roemmele, herself a victim of the disease. "But it's been heartbreaking and frustrating that the long-time standard of care has been so tragically inadequate.  Every single day I get calls and emails from yet another missed or misdiagnosis.  A metaphor used often by medical professionals in regard to making a diagnosis is: 'If you hear hoofbeats outside your window; chances are it is a horse and not a zebra.'  A deadly case of NF is often dismissed as the zebra, which should not be the case when faced with patients presenting with classic symptoms – pain out of proportion to the injury, fever, or severe flulike symptoms."

What's urgently needed is for the medical profession to develop and adopt a new standard of care for the life-threatening disease. This new standard of care could be based on a ground-breaking treatment described in a recent paper in the journal WOUNDS by John Crew, MD, FACS, medical director and lead vascular surgeon at the San Francisco Center for Advanced Wound Care at Seton Medical Center in Daly City, Calif. The basic idea is to neutralize the toxins that eat away flesh by irrigating the wounds of necrotizing fasciitis patients with a substance called hypochlorous acid (HOCl), a natural chemical produced by white blood cells as a first defense against microbial invaders. Laboratory studies have shown that in addition to killing bacteria, hypochlorous acid neutralizes the toxins and appears to stop the spread of the dying tissue. When used in combination with a common vacuum technique called negative pressure wound therapy, irrigation with HOCl has successfully saved the lives and limbs of every patient treated to date with the technique.

"This approach could become the basis of a new, better standard of care," says Roemmele.

Source: National Necrotizing Fasciitis Foundation (NNFF)
 

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content